Clinical Investigator Career Development Award
The Lymphoma Research Foundation’s Clinical Investigator Career Development Award (CDA) supports advanced fellows and junior faculty—licensed physician investigators in the U.S. and Canada—to build independent clinical research careers in lymphoma by funding protected research time, protocol development, and trial implementation .
Eligibility Criteria:
-
Physician Status: Licensed MD/DO (or equivalent) in an ACGME‐accredited specialty (e.g., hematology/oncology, pathology) at a nonprofit academic or clinical research institution in the U.S. or Canada.
-
Career Stage: Advanced fellow or junior faculty with ≥24 months of fellowship/postdoctoral training and ≤6 years of post‐training experience as of March 1, 2026 (extensions for major life events allowed).
-
Research Commitment: Devote 35–50% FTE to lymphoma clinical research, free from major clinical, teaching, or administrative duties.
-
Project Scope: Hypothesis‐driven clinical research in lymphoma/CLL per WHO classification; translational aims permitted but not primary.
-
Independence: Applicant must lead study design, IRB submission, conduct, analysis, and publication of clinical protocols.
-
Mentorship: Identify a primary mentor (and up to four associate mentors) with demonstrated training records; mentors submit biosketches and letters of support.
-
Concurrent Awards: May not hold another career development award (e.g., NIH K‐series, ACS CSDG) during the CDA period.
Funding Details:
-
Total Amount: US $375,000 over 3 years
-
Salary Support: US $120,000/year
-
Incidental Funds: US $5,000/year for supplies or professional development
-
-
Duration: 3 years (must start between March 1 and July 1, 2026)
-
Allowable Costs: Applicant salary; research supplies; tuition, registration, and travel integral to the career development plan.
-
Exclusions: No institutional overhead; no funding for non‐PI personnel salaries or equipment purchase.
Deadline:
-
Application Release: June 2, 2025
-
Submission Deadline: September 4, 2025, 5:00 PM EST
-
Peer Review: September–November 2025
-
Notification: December 2025
-
Project Start Window: March 1 – July 1, 2026
Where to Go for Further Information & Application:
Apply online via Proposal Central.
Contact the LRF Research Grants team with eligibility or application questions: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023